Ovoca Bio | OVG - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
ALKERMES USD 196.64M 67.96M 2026-06
Avita Medical AUD 19.03M 1.95M 2025-12
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Great Western Mining Corporation EUR 595.79K 109.22K 2025-12
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
IQVIA Holdings USD 574M 72M 2026-06
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 216M 43M 2026-06
Organon & Co USD 434M 10M 2026-06
Ovoca Bio EUR 617K 15K 2025-12
Revvity USD 278.58M 24.69M 2026-06
Tectonic Therapeutic USD 6.43M 2.99M 2026-03
Viatris USD 1.13B 205.7M 2026-06
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03